Archives

by in
Entry Author Date Location
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
SD Life Sciences Roundup: Arena, PatientSafe, MEI Pharma, & More 06/28/12 San Diego
Onyx Shares Boom on Positive FDA Panel for Myeloma Drug 06/21/12 San Francisco
Join Us Today for a Tweetchat at Noon ET/9 am PT With Katrine Bosley 06/19/12 National
Join Us for BIO Tweetchat at 12:30 pm ET with John Maraganore 06/15/12 National
The 2012 New York ASCO Checklist 05/24/12 New York
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
Genzyme, Epizyme, & Rib-X Among the Week’s Life Sciences Newsmakers 04/27/12 Boston
Epizyme Gets $90M in Epigenetics Partnership with Celgene 04/26/12 Boston
Xconomy Boston’s Top 20 Stories of Q1: Editor’s Picks 04/02/12 Boston
Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation 03/29/12 Boston
Glaxo and J&J’s Shrewd Move Will Help the Biotech Ecosystem 03/23/12 National
Synchroneuron, Radius, Acetylon, & More Boston Life Sciences News 02/10/12 Boston
Celgene Pours $15M Into Acetylon, Takes “Observer” Role on Board 02/09/12 Boston
Avila, iRobot, Verastem, Illume, & More Boston Deal News 02/01/12 Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
Shout Outs for Avila From Polaris, Atlas, & the Twittersphere 01/26/12 Boston
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs 01/26/12 Boston
Foundation Medicine and Sanofi Form Cancer Discovery Pact 01/10/12 Boston
Forma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week 01/10/12 Boston
Acceleron Adds $30M From Partner Celgene and Existing Investors 12/23/11 Boston
Onyx Drug Effective in New Myeloma Patients, Taking Aim at Millennium 12/12/11 San Francisco
Allena Kicks Off With $15M, Security Firms Ink Funding, TeraDiode Takes In $10M, & More Boston-Area Deals News 11/23/11 Boston
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News 11/18/11 Boston
Agios Nabs $78M From Partner Celgene, Existing VCs, and Public Funds 11/17/11 Boston
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Celgene To Pump $45M into Quanticel to Discover Cancer Drugs, Gets Option To Acquire 11/04/11 San Francisco
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter 10/28/11 Boston
Kleiner Perkins, Google Ventures Join Expanded $33.5M Round for Foundation Medicine 10/18/11 Boston
Page 2 of 4 « previous page · next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.